ID   OMC-1 [Human ovarian carcinoma]
AC   CVCL_9T73
DR   Cosmic; 2429302
DR   Wikidata; Q54932032
RX   DOI=10.15114/smj.55.153;
RX   PubMed=19154404;
RX   PubMed=22246397;
CC   Population: Japanese.
CC   Doubling time: 24 hours (DOI=10.15114/smj.55.153).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
RX   DOI=10.15114/smj.55.153;
RA   Hayakawa O., Tsumura N., Koizumi M., Endo T., Kudo R.;
RT   "Establishment and characterization of cell line (OMC-1) derived from
RT   mucinous cystadenocarcinoma of human ovary.";
RL   Sapporo Igaku Zasshi 55:153-160(1986).
//
RX   PubMed=19154404; DOI=10.1111/j.1349-7006.2008.01065.x;
RA   Sato S., Itamochi H., Kigawa J., Oishi T., Shimada M., Sato S.,
RA   Naniwa J., Uegaki K., Nonaka M., Terakawa N.;
RT   "Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an
RT   effective regimen for mucinous adenocarcinoma of the ovary: a
RT   potential treatment strategy.";
RL   Cancer Sci. 100:546-551(2009).
//
RX   PubMed=22246397; DOI=10.3892/or.2012.1626;
RA   Sato N., Saga Y., Mizukami H., Wang D., Fujiwara H., Takei Y.,
RA   Machida S., Ozawa K., Suzuki M.;
RT   "Cetuximab inhibits the growth of mucinous ovarian carcinoma tumor
RT   cells lacking KRAS gene mutations.";
RL   Oncol. Rep. 27:1336-1340(2012).
//